Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma

Oral Oncology

Volumn 43, Issue 10, 2007, Pages 1021-1025

  Kim, Chul Ho ^a   Lee, Jin Seok ^b   Kang, Sung Ook ^a   Bae, Joon ho ^a   Hong, Sung Pyo ^a   Kahng, Hison ^a  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Head and neck cancer; Hepatocyte growth factor; Serum

Indexed keywords

SCATTER FACTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 34948844001     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.11.016     Document Type: Article

References (32)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
2. Hanzawa M., Shindoh M., Higashino F., Yasuda M., Inoue N., Hida K., et al. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21 (2000) 1079-1085
3. Montesano R., Matsumoto K., Nakamura T., and Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67 (1991) 901-908
4. Barros E.J., Santos O.F., Matsumoto K., Nakamura T., and Nigam S.K. Differential tubulogenic and branching morphogenetic activities of growth factors: implications for epithelial tissue development. Proc Natl Acad Sci USA 92 (1995) 4412-4416
5. Zarnegar R., and Michalopoulos G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129 (1995) 1177-1180
6. Yoshinaga Y., Matsuno Y., Fujita S., Nakamura T., Kikuchi M., Shimosato Y., et al. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 84 (1993) 1150-1158
7. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
8. Di Renzo M.F., Poulsom R., Olivero M., Comoglio P.M., and Lemoine N.R. Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55 (1995) 1129-1138
9. Toi M., Taniguchi T., Ueno T., Asano M., Funata N., Sekiguchi K., et al. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res 4 (1998) 659-664
10. Maemura M., Iino Y., Yokoe T., Horiguchi J., Takei H., Koibuchi Y., et al. Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer. Cancer Lett 126 (1998) 215-220
11. Fukuura T., Miki C., Inoue T., Matsumoto K., and Suzuki H. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer 78 (1998) 454-459
12. Siegfried J.M., Weissfeld L.A., Luketich J.D., Weyant R.J., Gubish C.T., and Landreneau R.J. The clinical significance of hepatocyte growth factor for non-small cell lung cancer. Ann Thorac Surg 66 (1998) 1915-1918
13. Seidel C., Borset M., Turesson I., Abildgaard N., Sundan A., and Waage A. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The nordic myeloma study group. Blood 91 (1998) 806-812
14. Hjorth-Hansen H., Seidel C., Lamvik J., Borset M., Sundan A., and Waage A. Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. Eur J Haematol 62 (1999) 129-134
15. Wu C.W., Chi C.W., Su T.L., Liu T.Y., Lui W.Y., and P'Eng F.K. Serum hepatocyte growth factor level associate with gastric cancer progression. Anticancer Res 18 (1998) 3657-3659
16. Niki M., Isozaki H., Toyoda M., Ishibashi T., Fujii K., Nomura E., et al. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma. Hepatogastroenterology 46 (1999) 568-573
17. Grigioni W.F., D'Errico A., Fortunato C., Fiorentino M., Mancini A.M., Stetler-Stevenson W.G., et al. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 7 (1994) 220-225
18. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81 (1988) 414-419
19. Tomiya T., Nagoshi S., and Fujiwara K. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 15 (1992) 1-4
20. Matsumoto K., and Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem (Tokyo) 119 (1996) 591-600
21. Tsubouchi H. Hepatocyte growth factor for liver disease. Hepatology 30 (1999) 333-334
22. Kaido T., and Imamura M. Hepatocyte growth factor: clinical implications in hepatobiliary pancreatic surgery. J Hepatobiliary Pancreat Surg 8 (2001) 65-75
23. Kosai K., Matsumoto K., Funakoshi H., and Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30 (1999) 151-159
24. von Schweinitz D., Faundez A., Teichmann B., Birnbaum T., Koch A., Hecker H., et al. Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 85 (2000) 151-159
25. Druzgal C.H., Chen Z., Yeh N.T., Thomas G.R., Ondrey F.G., Duffey D.C., et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck Surg 27 (2005) 771-784
26. Lee K.H., Choi E.Y., Kim M.K., Hyun M.S., Jang B.I., Kim T.N., et al. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines. Exp Mol Med 38 (2006) 27-35
27. Hasina R., Matsumoto K., Matsumoto-Taniura N., Kato I., Sakuda M., and Nakamura T. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer 80 (1999) 1708-1717
28. Marshall D.D., and Kornberg L.J. Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma. Laryngoscope 108 (1998) 1413-1417
29. Kim C.H., Moon S.K., Bae J.H., Lee J.H., and Choi E.C. Effect of HGF in proliferation, dispersion and migration of hypopharyngeal squamous cell carcinoma. Korean J Otolaryngol 48 (2005) 208-215
30. Taniguchi T., Kitamura M., Arai K., Iwasaki Y., Yamamoto Y., Igari A., et al. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 75 (1997) 673-677
31. Han S.U., Lee J.H., Kim W.H., Cho Y.K., and Kim M.W. Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J Surg 23 (1999) 1176-1180
32. Naughton M., Picus J., Zhu X., Catalona W.J., Vollmer R.T., and Humphrey P.A. Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer. J Urol 165 (2001) 1325-1328